
Exploring how the clinical trial enterprise can benefit from new advances and emerging opportunities in digital health technology.
Exploring how the clinical trial enterprise can benefit from new advances and emerging opportunities in digital health technology.
After a period of "fits and starts," large pharma companies are increasingly investing in digital health tools to reach business goals, be they through internal investments or strategic partnerships.
Key considerations in deploying fit-for-purpose digital health technologies in drug development.
Harnessing advances in digital health technologies for a more precision-measured approach.
The potential of personal health records to bridge the gap between research and care.
Whether unstructured patient diaries will be part of future clinical trials depends on three main factors, including answers around added value.
Harnessing these tools for successful integration and streamlining of processes.
Five proactive steps industry can take to optimize a patient's clinical trial experience.
The concept of sludge provides an invaluable lens for clinical research professionals in identifying and mitigating unnecessary friction and bottlenecks.